Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Argan (AGX) over the last 8 years, with Q4 2025 value amounting to $7.5 million.

  • Argan's Other Accumulated Expenses fell 4081.39% to $7.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.5 million, marking a year-over-year decrease of 4081.39%. This contributed to the annual value of $19.2 million for FY2025, which is 12205.92% up from last year.
  • Latest data reveals that Argan reported Other Accumulated Expenses of $7.5 million as of Q4 2025, which was down 4081.39% from $18.4 million recorded in Q3 2025.
  • Argan's 5-year Other Accumulated Expenses high stood at $25.6 million for Q2 2025, and its period low was $7.5 million during Q4 2025.
  • Moreover, its 4-year median value for Other Accumulated Expenses was $12.6 million (2023), whereas its average is $13.1 million.
  • Within the past 5 years, the most significant YoY rise in Argan's Other Accumulated Expenses was 12205.92% (2025), while the steepest drop was 4081.39% (2025).
  • Quarter analysis of 4 years shows Argan's Other Accumulated Expenses stood at $13.4 million in 2022, then dropped by 17.19% to $11.1 million in 2023, then rose by 14.39% to $12.7 million in 2024, then plummeted by 40.81% to $7.5 million in 2025.
  • Its Other Accumulated Expenses stands at $7.5 million for Q4 2025, versus $18.4 million for Q3 2025 and $25.6 million for Q2 2025.